文献速递内脏/肾动脉与血管畸形

孤立性自发性肠系膜上动脉夹层的治疗策略结局:一项系统综述

Outcomes of Treatment Strategies for Isolated Spontaneous Dissection of the Superior Mesenteric Artery: A Systematic Review.
PubMed 文献 · Ann Vasc Surg · 2017-07-25

在无肠缺血或动脉瘤证据的症状性患者中,初始治疗以保守治疗为主(82.1%),介入治疗占14.3%;保守治疗组需额外治疗的比例(18.1%)高于介入治疗组(2.4%),但各治疗策略间死亡率无显著差异。

要点

  • 无肠缺血或动脉瘤证据的症状性SMA夹层患者,保守治疗与介入治疗死亡率无显著差异。
  • 保守治疗组需额外治疗的比例为18.1%,高于介入治疗组的2.4%。
  • 症状性SMA夹层初始治疗以保守治疗最常见,占82.1%。

核心结论

  • 在无肠缺血或动脉瘤证据的症状性SMA夹层患者中,介入治疗与保守治疗的死亡率无显著差异。
  • 保守治疗组需要额外治疗的比例高于介入治疗组。

研究设计与样本

  • 共纳入51篇文章、721例孤立性自发性SMA夹层患者。

主要发现

  • 无肠缺血或动脉瘤证据的症状性患者初始治疗:保守治疗82.1%,介入治疗14.3%,导管定向药物输注2.1%,手术1.5%。
  • 保守治疗组18.1%需要额外治疗,介入治疗组2.4%需要额外治疗(P = 0.0003)。
  • 各治疗策略间死亡率无显著差异(P = 0.92)。

关键数值与推荐

  • 额外治疗需求:保守治疗18.1% vs 介入治疗2.4%,P = 0.0003。
  • 死亡率比较:各治疗策略间P = 0.92。

临床怎么用

  • 对于无肠缺血或动脉瘤证据的症状性SMA夹层患者,可考虑保守治疗,但需警惕部分患者需额外治疗。
  • 介入治疗可减少额外治疗需求,但死亡率与保守治疗无差异。

局限性

  • 为系统综述,非随机对照试验,可能存在选择偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Isolated spontaneous dissection of the superior mesenteric artery (SMA) without aortic dissection is being increasingly recognized. This study aimed to evaluate the latest clinical characteristics and optimal treatment. METHODS: We searched the Cochrane Library, MEDLINE, and Clinical Trial.gov databases through December 31, 2016, using the following words: "superior mesenteric artery" and "dissection." We retrieved articles presenting the treatment and outcomes of isolated SMA dissection published in English. We investigated the patient characteristics, treatments, follow-up, and prognoses. Additionally, we compared mortality rates and assessed the need for additional interventions between treatment strategies in symptomatic patients without accompanying proof of bowel ischemia or aneurysm, which require immediate endovascular treatment or surgery. RESULTS: We identified 51 articles with 721 patients. The initial treatments in symptomatic patients without accompanying proof of bowel ischemia or aneurysm were conservative treatment (82.1%), endovascular treatment (14.3%), catheter-directed infusion of medication (2.1%), and surgery (1.5%). Additional treatment was needed in 18.1% of patients receiving conservative treatment and 2.4% of patients receiving endovascular treatment (P = 0.0003). Mortality was not significantly different between each treatment strategy (P = 0.92). CONCLUSIONS: There was no significant difference in mortality of symptomatic SMA dissection patients without accompanying proof of bowel ischemia or aneurysm between interventional treatment and conservative treatment. An additional treatment is needed in a minority of patients receiving conservative treatment, however, more frequently than in those receiving endovascular treatment.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Kimura Y, Kato T, Inoko M, et al. Outcomes of Treatment Strategies for Isolated Spontaneous Dissection of the Superior Mesenteric Artery: A Systematic Review. Ann Vasc Surg. 2017. PMID: 28751168. doi:10.1016/j.avsg.2017.07.027

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。